Abstract
Background: CD33 is mainly expressed in immune cells including macrophages and microglia, and causes inhibitory signal through the Src homology region 2 domain-containing protein tyrosine phosphatase-1 (SHP-1). CD33 variant is identified as a genetic risk for late-onset Alzheimer’s disease, and is linked to phagocytic capacity of amyloid β (Aβ).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
